Apogee Therapeutics, Inc.
Board Member
Lisa Bollinger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lisa Bollinger
Earlier roles on record: Board Member at Apogee Therapeutics, Inc. until September 3, 2026. Apogee Therapeutics, Inc. reported in an 8-K filed September 3, 2026 that Lisa Bollinger resigned as director, effective September 3, 2026.
“In connection with the Merger and effective as of, and contingent upon, the Effective Time, all of the Company's directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company's board of directors and the directors of Merger Sub immediately prior to the Effective Time became the directors of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Apogee Therapeutics, Inc.
Board Member
Proxy statement
Start not stated–2026-09-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.